Related Experiment Video
Updated: Jul 15, 2025

06:55
Bioengineering Human Microvascular Networks in Immunodeficient Mice
Published on: July 11, 2011
12.4K
Immunohistological responses in mice implanted with Parylene HT - ITO ECoG devices
Miklós Madarász1,2, Flóra Z Fedor1,3, Zoltán Fekete4,5
1BrainVision Center, Budapest, Hungary.
Frontiers in Neuroscience
|September 25, 2023
Summary
This study evaluated the biocompatibility of novel Parylene HT/indium-tin oxide (ITO) electrocorticography (ECoG) devices. Long-term implantation in mice showed manageable immune responses and confirmed the feasibility of these transparent ECoG devices for neuroscience research.
Area of Science:
- Neuroscience
- Biocompatibility Testing
- Implantable Medical Devices
Background:
- Transparent epidural devices enabling simultaneous electrophysiology and neuroimaging are emerging tools in neuroscience.
- Assessing the biocompatibility and immune response of novel implantable devices is crucial for their widespread adoption.
- Parylene HT/indium-tin oxide (ITO) based electrocorticography (ECoG) devices offer potential for advanced neural monitoring.
Purpose of the Study:
- To conduct an immunohistochemical evaluation of Parylene HT/ITO ECoG devices.
- To provide long-term biocompatibility data for these devices at various chronic implantation durations.
- To assess the evoked astroglial response, neuronal density, and cortical thickness following device implantation.
Main Methods:
- Epidural implantation of Parylene HT/ITO ECoG devices in 5 mice.
- Immunohistochemical analysis to evaluate astroglial response, neuronal density, and cortical thickness.
- Comparison of implanted brain tissue with contralateral unimplanted controls at multiple time points.
Main Results:
- Increased astroglial response observed in superficial cortical layers of implanted mice, diminishing over time.
- Reduced neuronal density noted only at the final time point on the implanted side.
- Decreased cortical thickness observed at earlier time points, but not at the final assessment.
Conclusions:
- Parylene HT/ITO ECoG devices demonstrate feasibility for chronic implantation.
- The study provides essential long-term biocompatibility data for these transparent neural devices.
- Findings support the continued development and application of these devices in neuroscience research.

